Review of the Expert Council “Multiple myeloma: the era of monoclonal antibodies in the treatment of patients with multiple myeloma”

QR Code

Review of the Expert Council “Multiple myeloma: the era of monoclonal antibodies in the treatment of patients with multiple myeloma”

.

Saved in:

Bibliographic Details
Main Authors:	M. I. Akhmedov, P. A. Zeynalova
Format:	Article
Language:	Russian
Published:	ABV-press 2024-01-01
Series:	Онкогематология
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/894
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Expert Council Review “Multiple myeloma”
by: M. I. Akhmedov, et al.
Published: (2023-05-01)

Comorbidities in patients with multiple myeloma
by: L. P. Kuznetsova, et al.
Published: (2019-08-01)

Expert Council resolution on the specifics of multiple myeloma therapy during COVID-19 pandemic
by: Article Editorial
Published: (2020-07-01)

Based on the seminar materials of the “Oncohematology” Journal Experts Council “Modern approaches to the refractory multiple myeloma treatment”
by: S. V. Semochkin
Published: (2021-11-01)

Multiple Myeloma and Dentistry
by: Shah, Ajaz, et al.
Published: (2012)

Results of multiple myeloma treatment with bortezomib
by: T. I. Pospelova, et al.
Published: (2022-11-01)

Treatment of bone complications in multiple myeloma patients
by: V. V. Ptushkin
Published: (2022-11-01)

The role of PET/CT in the diagnosis and response assessment in patients with multiple myeloma
by: A. E. Pankratov, et al.
Published: (2021-09-01)

Proteasome Inhibitors in the Treatment of Multiple Myeloma
by: Crawford, Lisa J., et al.
Published: (2012)

Treatment of double-refractory multiple myeloma
by: S. V. Semochkin
Published: (2021-09-01)

IMMUNE DISTURBANCES IN PATIENTS WITH MULTIPLE MYELOMA
by: E. A. Senkina, et al.
Published: (2014-07-01)

Multiple Myeloma with Intracranial Distribution
by: A. Yu. Rynda, et al.
Published: (2023-06-01)

Regulatory Cells and Multiple Myeloma
by: Raja, Karthick Raja Muthu, et al.
Published: (2012)

Renal Disease in Multiple Myeloma
by: Saydam, Guray, et al.
Published: (2012)

Modern therapy of multiple myeloma
by: O. M. Votyakova
Published: (2008-12-01)

The role of Capon in multiple myeloma
by: Yaodong Shen, et al.
Published: (2017-06-01)

Isatuximab in the treatment of refractory and relapsed multiple myeloma: literature review and case report
by: Yu. E. Ryabukhina, et al.
Published: (2023-12-01)

TREATMENT MANAGEMENT IN MULTIPLE MYELOMA WITH RENAL DISORDER
by: Meryem Sener
Published: (2025-07-01)

Neutrophilic hyperleukocytosis in the multiple myeloma onset
by: I. G. Rekhtina, et al.
Published: (2022-07-01)

Lenalidomide for relapsed or refractory multiple myeloma
by: S. S. Bessmeltsev1, et al.
Published: (2014-07-01)

A roadmap to implementing outpatient administration of bispecific antibodies in multiple myeloma
by: Alfred L. Garfall, et al.
Published: (2025-07-01)

Herpes zoster in multiple myeloma patients during bortezomib treatment
by: I. N. Nazarova, et al.
Published: (2014-07-01)

Cancer Stem Cells in Multiple Myeloma
by: Ciavarella, Sabino, et al.
Published: (2011)

Stem Cell Mobılızatıon in Multıple Myeloma
by: Bakanay, Şule Mine, et al.
Published: (2012)

Pitfalls in the pathological diagnosis of multiple myeloma
by: V. V. Baykov
Published: (2022-11-01)

Bone marrow adipocytes and multiple myeloma
by: A. A. Philchenkov
Published: (2019-04-01)

Onset of multiple myeloma with rheumatic polymyalgia
by: E. R. Israelyan, et al.
Published: (2019-12-01)

CD200 immune checkpoint expression is associated with inferior outcome in multiple myeloma patients treated with anti-CD38 monoclonal antibodies
by: Djamila Chemlal, et al.
Published: (2025-12-01)

The role of pomalidomide in treatment of relapse and refractory multiple myeloma
by: S. V. Voloshin, et al.
Published: (2022-01-01)

Modern strategies in therapy of elderly patients with multiple myeloma
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01)

Multiple myeloma and cardiovascular risk (a literature review)
by: B. B. Samura, et al.
Published: (2020-11-01)

Plasma cell dyscrasia: monoclonal gammopathies, AL-amyloidosis, multiple myeloma Clinical case study
by: V. V. Cherepanova, et al.
Published: (2023-03-01)

The role of bone marrow microenvironment in the progression of multiple myeloma from monoclonal gammopathy of undetermined significance
by: A. S. Khudovekova, et al.
Published: (2021-09-01)

Clinical features of multiple myeloma with bone plasmacytomas
by: E. A. Mamaeva, et al.
Published: (2023-03-01)

CLINICO-PATHOMORPHOLOGICAL STUDY OF MYELOFIBROSIS IN MULTIPLE MYELOMA
by: Yu. A. Dyachkova, et al.
Published: (2016-02-01)

Targeted Inhibition of Multiple Proinflammatory Signalling Pathways for the Prevention and Treatment of Multiple Myeloma
by: Kannaiyan, Radhamani, et al.
Published: (2012)

Cariohemodynamics in patients with multiple myeloma depending on renal function
by: B. B. Samura, et al.
Published: (2019-12-01)

CLINICAL MANIFESTATIONS OF VASCULITIS AT THE ONSET OF MULTIPLE MYELOMA
by: V I Vasil'ev, et al.
Published: (2010-02-01)

Impact of treatment delay of multiple myeloma bone disease on later myeloma-related skeletal events and outcome
by: Eskelinen Veera, et al.
Published: (2025-08-01)

DIAGNOSTIC OF NONSECRETORY MULTIPLE MYELOMA (CLINICAL CASE)
by: N. T. Vatutin, et al.
Published: (2017-03-01)